Sotrovimab for Pre-exposure Prophylaxis against SARS-CoV2 in a Vulnerable Patient Population: Results from the PROTECT-V trial
Chen-Xu et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofaf695.340
https://c19early.org/chenxu.html